Haploidentical transplantation for leukemia.
Haploidentical transplantation for leukemia.
复制标题
DOI:
10.1007/s11912-010-0113-4
复制
发表时间:
2010-09
影响因子:
4.7
通讯作者:
Rizzieri, David A.
中科院分区:
文献类型:
--
作者:
Kanda, Junya;Chao, Nelson J.;Rizzieri, David A.
关键词:
Hematopoietic stem cell transplantation from human leukocyte antigen (HLA)-haploidentical family members offers a potential cure for patients in need of allogeneic immunotherapy who have no immediate access to an HLA-matched donor. The use of ex vivo T-cell-depleted stem cells combined with immuno-myeloablative conditioning has enabled durable donor engraftment with a low incidence of acute graft-versus-host disease despite the HLA disparity. Moreover, additional transplant techniques involving in vivo T-cell-depletion and reduced-intensity conditioning have further minimized the risks. However, a major drawback is delayed immune reconstitution leading to infections and high relapse rates, prompting significant research efforts focused on improving recovery in the post-transplant period. Infusions with donor lymphocytes are common, though newer manipulations with a focus on donor natural killer cells hold great promise as does other modified donor T-cell infusions. Success of these new procedures will make haploidentical transplants safer and more effective, further broadening its appeal.
登录
查看更多内容
影响因子:
20.3
作者:
HensleeDowney, PJ;Abhyankar, SH;Gee, AP
通讯作者:
Gee, AP
影响因子:
45.3
作者:
Aversa, F;Terenzi, A;Martelli, MF
通讯作者:
Martelli, MF
影响因子:
4.3
作者:
Huang, Xiao-Jun;Liu, Dai-Hong;Lu, Dao-Pei
通讯作者:
Lu, Dao-Pei
影响因子:
158.5
作者:
Laughlin, MJ;Eapen, M;Horowitz, MM
通讯作者:
Horowitz, MM
影响因子:
2.3
作者:
Bethge, Wolfgang A.;Faul, Christoph;Kanz, Lothar
通讯作者:
Kanz, Lothar